Bioteque Asset Resilience Ratio
Bioteque asset resilience ratio. Bioteque (4107) has an Asset Resilience Ratio of 17.17% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 4107 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Bioteque (2006–2025)
Asset resilience ratio of Bioteque from 2006 to 2025. This chart shows how Bioteque's Asset Resilience Ratio has changed over time. Read total liabilities of Bioteque for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Bioteque's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Bioteque.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$838.09 Million | 17.17% |
| Total Liquid Assets | NT$838.09 Million | 17.17% |
Asset Resilience Insights
- Good Liquidity Position: Bioteque maintains a healthy 17.17% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Bioteque Industry Peers by Asset Resilience Ratio
Compare Bioteque's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Crossject
PA:ALCJ |
Medical Instruments & Supplies | 1.31% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
Bioteque Asset Resilience Ratio by Year (2006–2025)
Bioteque asset resilience ratio by year from 2006 to 2025. The table below shows the annual Asset Resilience Ratio data for Bioteque.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 10.88% | NT$506.88 Million ≈ $15.97 Million |
NT$4.66 Billion ≈ $146.82 Million |
+3.13pp |
| 2024-12-31 | 7.75% | NT$360.09 Million ≈ $11.34 Million |
NT$4.65 Billion ≈ $146.36 Million |
+3.19pp |
| 2023-12-31 | 4.56% | NT$210.72 Million ≈ $6.64 Million |
NT$4.62 Billion ≈ $145.57 Million |
-1.02pp |
| 2022-12-31 | 5.59% | NT$250.26 Million ≈ $7.88 Million |
NT$4.48 Billion ≈ $141.16 Million |
-5.80pp |
| 2021-12-31 | 11.38% | NT$439.50 Million ≈ $13.85 Million |
NT$3.86 Billion ≈ $121.64 Million |
+3.17pp |
| 2020-12-31 | 8.21% | NT$292.60 Million ≈ $9.22 Million |
NT$3.56 Billion ≈ $112.28 Million |
+2.14pp |
| 2019-12-31 | 6.07% | NT$178.63 Million ≈ $5.63 Million |
NT$2.94 Billion ≈ $92.64 Million |
-0.36pp |
| 2018-12-31 | 6.43% | NT$178.27 Million ≈ $5.62 Million |
NT$2.77 Billion ≈ $87.32 Million |
-0.24pp |
| 2017-12-31 | 6.67% | NT$174.98 Million ≈ $5.51 Million |
NT$2.62 Billion ≈ $82.59 Million |
-0.61pp |
| 2016-12-31 | 7.28% | NT$186.68 Million ≈ $5.88 Million |
NT$2.56 Billion ≈ $80.77 Million |
-0.15pp |
| 2015-12-31 | 7.43% | NT$186.15 Million ≈ $5.86 Million |
NT$2.50 Billion ≈ $78.88 Million |
-0.29pp |
| 2014-12-31 | 7.73% | NT$181.38 Million ≈ $5.71 Million |
NT$2.35 Billion ≈ $73.94 Million |
-2.32pp |
| 2013-12-31 | 10.05% | NT$200.75 Million ≈ $6.32 Million |
NT$2.00 Billion ≈ $62.92 Million |
-10.05pp |
| 2012-12-31 | 20.10% | NT$326.94 Million ≈ $10.30 Million |
NT$1.63 Billion ≈ $51.24 Million |
+2.24pp |
| 2011-12-31 | 17.86% | NT$290.81 Million ≈ $9.16 Million |
NT$1.63 Billion ≈ $51.30 Million |
-3.12pp |
| 2010-12-31 | 20.98% | NT$353.44 Million ≈ $11.14 Million |
NT$1.69 Billion ≈ $53.09 Million |
+1.12pp |
| 2009-12-31 | 19.85% | NT$342.91 Million ≈ $10.80 Million |
NT$1.73 Billion ≈ $54.41 Million |
-0.12pp |
| 2008-12-31 | 19.98% | NT$343.94 Million ≈ $10.84 Million |
NT$1.72 Billion ≈ $54.25 Million |
+6.61pp |
| 2007-12-31 | 13.37% | NT$220.71 Million ≈ $6.95 Million |
NT$1.65 Billion ≈ $52.02 Million |
-3.29pp |
| 2006-12-31 | 16.66% | NT$218.09 Million ≈ $6.87 Million |
NT$1.31 Billion ≈ $41.25 Million |
-- |
About Bioteque
Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company offers angiography catheter, balloon dilation catheter, guiding sheath, guide steel wire, y-type connector, multi-pipe joint, connecting pipe, y-type connector assembly, peripheral vascular guiding catheter, coronary balloon dilation catheter, central venous catheter… Read more